ÀÚµ¿·Î±×¾Æ¿ô¾È³»
ÀÚµ¿ ·Î±×¾Æ¿ô ³²Àº ½Ã°£ : 30ÃÊ
°í°´´ÔÀÇ ¾ÈÀüÇÑ Á¤º¸º¸¾ÈÀ» À§ÇØ ·Î±×ÀÎ ÈÄ ¾à10ºÐµ¿¾È ¼ºñ½º ÀÌ¿ëÀÌ ¾ø¾î ÀÚµ¿ ·Î±×¾Æ¿ô µË´Ï´Ù. ·Î±×ÀÎ ½Ã°£À» ¿¬ÀåÇϽðڽÀ´Ï´Ù?
ÀÚµ¿·Î±×¾Æ¿ô¾È³»
°í°´´ÔÀÇ ¾ÈÀüÇÑ Á¤º¸º¸¾ÈÀ» À§ÇØ ·Î±×ÀÎ ÈÄ ¾à10ºÐµ¿¾È ¼ºñ½º ÀÌ¿ëÀÌ ¾ø¾î ÀÚµ¿ ·Î±×¾Æ¿ô µÇ¾ú½À´Ï´Ù.
±¸ºÐ | ºÐ·ù | Ç׸ñ | °¡°ÝÁ¤º¸ (´ÜÀ§ : ¿ø) | ƯÀÌ»çÇ× | ÃÖÁ¾º¯°æÀÏ | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
¸íĪ | ÄÚµå | ±¸ºÐ | ºñ¿ë | ÃÖÀúºñ¿ë | ÃÖ´ëºñ¿ë | Ä¡·áÀç·á´ë Æ÷ÇÔ¿©ºÎ |
¾àÁ¦ºñ Æ÷ÇÔ¿©ºÎ |
||||
°Ë»ç·á | ³»ºÐºñ°Ë»ç | anti-insulin receptor(±¹¿ÜÀ§Å¹) | CZ210 | 398,860 | 2022-12-01 | ||||||
°Ë»ç·á | ÁöÁú, ¿µ¾ç °ü·Ã°Ë»ç | sdLDL ÄÝ·¹½ºÅ×·Ñ °Ë»ç(ÈÇйÝÀÀ-ÀåºñÃøÁ¤) | CZ135 | 45,320 | 2024-05-01 | ||||||
óġ¹× ¼ö¼ú·á | ±âº»Ã³Ä¡·á | °¡¿Â°¡½À °íÀ¯·® ºñ° ij´¼¶ó¿ä¹ý[Àú»ê¼ÒÁõ ¿¹¹æ] | EEX300 | 28,800 | 2022-09-07 | ||||||
°Ë»ç·á | ³»½Ã°æ | °¡À̵å½Ã½º¸¦ ÀÌ¿ëÇÑ ±â°üÁö³»½Ã°æÃÊÀ½ÆÄ | EZ991 | 750,000 | 2024-05-28 | ||||||
Ä¡°úÀÇ º¸Ã¶·á | ±³Á¤·á | °¡Ã¶½Ä°íÁ¤ÀåÄ¡[ACTIVE PLATE] | NPIS0003 | 300,000 | Ãּұݾ×À¸·Î »óÅ¿¡ µû¶ó º¯°æ°¡´É | 2018-01-01 | |||||
Ä¡°úÀÇ º¸Ã¶·á | ±³Á¤·á | °¡Ã¶½Ä°íÁ¤ÀåÄ¡[PASSIVE PLATE] | NPIS0003 | 100,000 | Ãּұݾ×À¸·Î »óÅ¿¡ µû¶ó º¯°æ°¡´É | 2018-01-01 | |||||
Ä¡°úÀÇ º¸Ã¶·á | ±³Á¤·á | °¡Ã¶½Ä±³Á¤·á ÀåÂø·á | NPIS0003 | 500,000 | Ãּұݾ×À¸·Î »óÅ¿¡ µû¶ó º¯°æ°¡´É | 2018-01-01 | |||||
Ä¡°úÀÇ º¸Ã¶·á | ±³Á¤·á | °£°ÝÀ¯ÁöÀåÄ¡[¼Ò¾Æ] | NPIS0003 | 100,000 | Ãּұݾ×À¸·Î »óÅ¿¡ µû¶ó º¯°æ°¡´É | 2018-01-01 | |||||
°Ë»ç·á | ¼Òȱâ±â´É°Ë»ç | °£¼¶À¯È°Ë»ç[A] | EZ829 | 100,000 | 2023-11-08 | ||||||
°Ë»ç·á | ¼Òȱâ±â´É°Ë»ç | °£¼¶À¯È°Ë»ç[°ÇÁø´Üü] | EZ829 | 70,000 | 2020-04-06 | ||||||
°Ë»ç·á | ¼Òȱâ±â´É°Ë»ç | °£¼¶À¯È°Ë»ç[°ÇÁø¿ë] | EZ829 | 90,000 | 2020-04-06 | ||||||
±âº»Áø·á·á | ±³À°»ó´ã·á | °£Áúȯ ½Ä»ç»ó´ã | 12,200 | 2017-02-01 | |||||||
ÃÊÀ½ÆÄ | ÃÊÀ½ÆÄ | °©»ó¼±,°æºÎÃÊÀ½ÆÄ(µµÇ÷¯) | EB414 | 199,700 | 2019-09-02 | ||||||
ÃÊÀ½ÆÄ | ÃÊÀ½ÆÄ | °©»ó¼±ÃÊÀ½ÆÄÈÄ ¼¼Ä§°Ë»ç(¾çÃø)(¿ÜºÎ) | EB414 | 302,200 | 2018-08-14 | ||||||
ÃÊÀ½ÆÄ | ÃÊÀ½ÆÄ | °©»ó¼±ÃÊÀ½ÆÄÈÄ ¼¼Ä§°Ë»ç(ÆíÃø)(¿ÜºÎ) | 248,800 | 2023-04-12 |